Viridis Laboratories and Viridis North, located in Lansing and Bay City, respectively, filed a lawsuit last week against the MRA and several employees at the agency after the MRA said it had identified inaccurate and/or unreliable results of many cannabis products tested by the labs over a three-month period.
The health and safety bulletin issued by the agency said the affected products either needed to be retested for the microbials compliance panel or thrown away, suggesting there could be mold, specifically Aspergillus, in the cannabis products.
However, in the lawsuit, the labs said there was no public or safety risk to justify the recall, and instead said the MRA was unfairly targeting Viridis as a way to drive more business to other labs. Viridis tests between 60%-70% of the legal cannabis industry's products, or about $229 million worth, the lawsuit estimated.
After hearing both parties, Judge Christopher Murray decided that only half of the products that had to be taken off the market will be recalled. "Public safety concerns are one of the main purposes and duties of the MRA, and undoubtedly it believes the recall of both Viridis and Viridis North was necessary to protect the public," Murray wrote in his 13-page opinion and order. "But when there is no evidence that Viridis North’s testing also fit into that category of being dangerous to public health, the safety concerns are reduced," he said.
Read the complete article at freep.com.